Skip to content
Screener

CapEx at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.32B+26.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$240.2M+9.7%
Sight Sciences, Inc. logo
Sight Sciences, Inc.SGHT
$19K-91.0%
AbbVie logo
AbbVieABBV
$265M+12.8%
Schering-Plough logo
Schering-PloughSGP
$676K+312%
Bausch + Lomb logo
Bausch + LombBLCO
$71M-20.2%

Other financials

Income statement

See full
Revenue$185.6M+49.5%
Gross profit$151.6M+55.9%
Operating income-$17.3M+23.9%
Net income-$18.4M+6.5%
EPS (diluted)-$0.31+8.8%

Balance sheet

See full
Cash & equivalents$114.5M+13.6%
Total debt$105.9M-1.4%
Total equity$682.5M-10.8%
Total assets$920.5M-6.7%

Cash flow

See full
Operating cash flow$14.8M
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$10.08B+98.7%
Enterprise value$10.07B+98.2%
P/S16.5×+4.7×

Profitability

See full
Gross margin61%-15.4pp
Operating margin-31.6%+22.2pp
Net margin-30.7%+23.3pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26%-11,301pp
Debt / equity0.2×0.0×
Current ratio-0.5×

Where this comes from

Reported directly by Glaukos in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Glaukos’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-324201
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Investing activities
Purchases of short-term investments(66,847)(116,765)
Proceeds from sales and maturities of short-term investments82,62994,411
Purchases of property and equipment(6,697)(3,117)
Investment in company-owned life insurance(3,887)(2,465)
Cash paid for acquisitions, net of cash acquired-(12,437)
Purchase of real estate property-(16,607)
Other investing activities-(750)

Item 1. Financial Statements

FAQ

What is Glaukos's capex?
Glaukos (GKOS) reported capex of $2.74M in Q2 2026.
How has Glaukos's capex changed year-over-year?
Glaukos's capex increased by 132.2% year-over-year, from $1.18M to $2.74M.
What is the long-term trend for Glaukos's capex?
Over 4 years (2021 to 2025), Glaukos's capex has grown at a -36.7% compound annual growth rate (CAGR), from $47.79M to $7.67M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ask your AI about Glaukos's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude